Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial
about
Therapeutic Differences in 24-h Ambulatory Blood Pressures in Patients Switched Between Bioequivalent Nifedipine Osmotic Systems With Differing Delivery Technologies.Between-Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial.Evaluating the Feasibility of Use of a Foreign Reference Product for Generic Drug Applications: A Retrospective Pilot Study.Clinical Pharmacology & Therapeutics: Past, Present, and Future.Dry Powder Inhalers and Humidity: Another Factor to Consider to Ensure Adequate Lung Delivery.Single Batch Bioequivalence Paradigm for Orally Inhaled Products: Time for Change.
P2860
Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Batch-to-batch pharmacokinetic ...... aler randomized clinical trial
@en
Batch-to-batch pharmacokinetic ...... ler randomized clinical trial.
@nl
type
label
Batch-to-batch pharmacokinetic ...... aler randomized clinical trial
@en
Batch-to-batch pharmacokinetic ...... ler randomized clinical trial.
@nl
prefLabel
Batch-to-batch pharmacokinetic ...... aler randomized clinical trial
@en
Batch-to-batch pharmacokinetic ...... ler randomized clinical trial.
@nl
P2093
P2860
P356
P1476
Batch-to-batch pharmacokinetic ...... aler randomized clinical trial
@en
P2093
P2860
P304
P356
10.1002/CPT.373
P407
P577
2016-04-28T00:00:00Z